Levy J
Service de Pédiatrie, Centre Hospitalier Universitaire Saint-Pierre, Bruxelles.
Rev Med Brux. 1996 Sep;17(4):250-2.
Immunization against Haemophilus influenzae b and hepatitis B during infancy, as well as the administration of a second dose of measles-mumps-rubella vaccine around the age of 12, are the significant additions brought to the childhood immunization program in recent years. The availability in the near future of the acellular pertussis vaccines illustrates the efforts made to reduce the side effects associated with the use of some vaccines. The high cost of these acellular vaccines, together with the absence of combined Haemophilus influenzae or hepatitis B vaccines, represent their current limitations.
婴儿期接种B型流感嗜血杆菌疫苗和乙肝疫苗，以及在12岁左右接种第二剂麻疹-腮腺炎-风疹疫苗，是近年来儿童免疫规划的重大新增内容。无细胞百日咳疫苗在不久的将来可供使用，这表明人们为减少某些疫苗使用所带来的副作用做出了努力。这些无细胞疫苗的高成本，以及缺乏B型流感嗜血杆菌或乙肝联合疫苗，是它们目前的局限性所在。
